Connor, Clark & Lunn Investment Management (CC&L)’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,325
| Closed | -$425K | – | 1140 |
|
|
2020
Q4 | $425K | Buy |
+3,325
| New | +$425K | ﹤0.01% | 743 |
|
|
2015
Q2 | – | Sell |
-10,300
| Closed | -$392K | – | 681 |
|
|
2015
Q1 | $392K | Sell |
10,300
-3,600
| -26% | -$137K | ﹤0.01% | 426 |
|
|
2014
Q4 | $542K | Buy |
+13,900
| New | +$542K | ﹤0.01% | 379 |
|